Home › Funds › Morgan Stanley › ABVX

Morgan Stanley position in ABVX

ABIVAX SA · Health Care

Latest position (Q2 2026)1.43M sh
Reported value held$190.85M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q4 2023 427.95K $4.58M New
Q1 2024 593.46K $8.49M Add
Q2 2024 563.55K $7.45M Reduce
Q3 2024 504.75K $5.81M Reduce
Q4 2024 479.33K $3.51M Reduce
Q1 2025 497.15K $3.11M Add
Q2 2025 475.28K $3.64M Reduce
Q3 2025 1.47M $124.86M Add
Q4 2025 3.15M $425.06M Add
Q1 2026 1.70M $189.85M Reduce
Q2 2026 1.43M $190.85M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ABVX

All ABVX fund holders →